Table II.
Euroqol five dimensions questionnaire EQ-5D-5L
| Dimension | Baselinen (%) | Week 12 after lastadministration n (%) |
|---|---|---|
| Mobility problems | ||
| None | 2 (18.2) | 7 (63.6) |
| Slight | 1 (9.1) | 1 (9.1) |
| Moderate | 5 (41.7) | 0 |
| Severe | 3 (27.3) | 3 (27.3) |
| Unable to walk | 0 | 0 |
| Self-care problems | ||
| None | 1 (9.1) | 7 (63.6) |
| Slight | 5 (41.7) | 2 (18.2) |
| Moderate | 3 (27.3) | 2 (18.2) |
| Severe | 2 (18.2) | 0 |
| Unable to wash or dress | 0 | 0 |
| Usual activities problems | ||
| None | 2 (18.2) | 7 (63.6) |
| Slight | 2 (18.2) | 1 (9.1) |
| Moderate | 3 (27.3) | 2 (18.2) |
| Severe | 4 (36.4) | 1 (9.1) |
| Unable to do usual activities | 0 | 0 |
| Pain/discomfort | ||
| None | 0 | 4 (36.4) |
| Slight | 1 (9.1) | 2 (18.2) |
| Moderate | 2 (18.2) | 3 (27.3) |
| Severe | 7 (63.6) | 2 (18.2) |
| Extreme | 1 (9.1) | 0 |
| Anxiety/depression | ||
| Not anxious/depresses | 0 | 4 (36.4) |
| Slightly | 4 (36.4) | 4 (36.4) |
| Moderately | 1 (9.1) | 2 (18.2) |
| Severely | 5 (41.7) | 1 (9.1) |
| Extremely | 1 (9.1) | 0 |